Interactions of Ceftazidime and Amikacin on Multiresistant Pseudomonas aeruginosa : Have They Altered in the Six-Year Period from 1988 to 1994?

Author： Giamarellos-Bourboulis E.J.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.16, Iss.2, 1998-08, pp. : 167-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic interactions of ceftazidime, imipenem and aztreonam with amikacin in healthy volunteers

By Adamis G.   Papaioannou M.G.   Giamarellos-Bourboulis E.J.   Gargalianos P.   Kosmidis J.   Giamarellou H.  

International Journal of Antimicrobial Agents, Vol. 23, Iss. 2, 2004-02 ,pp. : 144-149

Elsevier

Access to resources Recommend Favorite

Correlation of the Pharmacokinetic Parameters of Amikacin and Ceftazidime

By Panomvana Duangchit  

Clinical Pharmacokinetics, Vol. 46, Iss. 10, 2007-01 ,pp. : 859-866

Adis International

Access to resources Recommend Favorite

Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa

By El-Sukhon S.N.   Faiza Boukhatem Z.  

International Journal of Antimicrobial Agents, Vol. 22, Iss. 6, 2003-12 ,pp. : 613-617

Elsevier

Access to resources Recommend Favorite

Nebulized liposomal amikacin for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients

By Ehsan Zarmina   Wetzel Jacqueline Denise   Clancy John P  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 743-749

Informa Healthcare

Access to resources Recommend Favorite

From the archives: how much progress have we really made?

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 2-3

Adis International

Access to resources Recommend Favorite